Literature DB >> 10962600

The value of the Kurtzke Functional Systems Scales in predicting incomplete bladder emptying.

K Kirchhof1, C J Fowler.   

Abstract

STUDY
DESIGN: A field study was conducted in 40 patients with multiple sclerosis (MS) by comparing their residual urine volumes with the Kurtzke Functional Systems Scales for pyramidal (PFS) or bladder functions (BFS).
OBJECTIVES: To determine whether raised residual urine volumes necessitating intermittent self catheterisation can be predicted by the PFS or BFS.
SETTING: Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals Trust, London, UK.
METHODS: In 40 patients with MS, post micturition residual volumes were measured with ultrasound prior to any treatment of bladder dysfunction. The patients' symptoms were assessed using PFS and BFS. Correlation between PFS, BFS and post micturition residual volumes were calculated as were sensitivity and specificity of PFS and BFS in predicting incomplete bladder emptying with residuals above 100 ml.
RESULTS: None of the patients with a PFS or BFS of 0 or 1 had a residual of more than 100 ml. There was a linear progression of maximal residuals with PFS and BFS. Correlation between PFS (BFS) and the post micturition residual volumes was 0.37 (0.71).
CONCLUSION: Unless a patient with MS has a PFS or BFS of greater than 1 they are unlikely to have incomplete bladder emptying with post micturition residual volumes above 100 ml. With PFS of BFS greater than 1 measurement of the post voiding residual volume is mandatory.

Entities:  

Mesh:

Year:  2000        PMID: 10962600     DOI: 10.1038/sj.sc.3101022

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  6 in total

Review 1.  Integrated control of lower urinary tract--clinical perspective.

Authors:  Clare J Fowler
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group.

Authors:  A Ghezzi; R Carone; G Del Popolo; M P Amato; A Bertolotto; M Comola; U Del Carro; P Di Benedetto; A Giannantoni; M L Lopes de Carvalho; E Montanari; F Patti; A Protti; S Rasia; A Salonia; C Scandellari; F Sperli; M Spinelli; C Solaro; A Uccelli; M Zaffaroni; V Zipoli
Journal:  Neurol Sci       Date:  2011-12       Impact factor: 3.307

3.  Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Authors:  A Ghezzi; E Mutta; F Bianchi; S Bonavita; F Buttari; A Caramma; R Cavarretta; D Centonze; G C Coghe; G Coniglio; U Del Carro; M T Ferrò; M G Marrosu; F Patti; M Rovaris; M Sparaco; I Simone; C Tortorella; R Bergamaschi
Journal:  Neurol Sci       Date:  2015-11-27       Impact factor: 3.307

Review 4.  [Diagnosis of neurogenic bladder dysfunction].

Authors:  A Kaufmann; I Kurze
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

Review 5.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

6.  Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.

Authors:  Vivien Li; Jalesh N Panicker; Collette Haslam; Jeremy Chataway
Journal:  J Neurol       Date:  2020-07-16       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.